Vijuve Inc v. Kaspien Inc

District Court, E.D. Washington·Decided June 26, 2023·No. 2:21-cv-00192·Unknown

Opinion

FILED IN THE EASTERU N. S D. I SD TI RS IT CR TI C OT F C WO AU SR HT I NGTON Jun 26, 2023 SEAN F. MCAVOY, CLERK VIJUVE INC., a Florida corporation, Plaintiff, No. 2:21-CV-00192-SAB v. KASPIEN INC., a Washington ORDER GRANTING MOTION corporation, FOR SUMMARY JUDGMENT; Defendant. DISMISSING MOTION TO Before the Court is Defendant Kaspien’s Motion for Summary Judgment, ECF No. 103, and Plaintiff Vijuve’s Motion to Strike Defendant Kaspien’s Surreply, ECF No. 123. The Court heard oral argument on June 13, 2023 by videoconference. Defendant Kaspien Inc. (“Kaspien”) was represented by Charles Hausberg and Zaine Yzaguirre; Mr. Hausberg presented on behalf of Defendant. Plaintiff Vijuve Inc. (“Vijuve”) was represented by Constance Proctor and Edward Redmond; Mr. Redmond presented on behalf of Plaintiff. This case involves a contract dispute between two companies: Vijuve, a company selling skincare products, and Kaspien, a company helping to sell these skincare products on Amazon. Vijuve alleges that Kaspien breached their contract by refusing to make a required minimum purchase order of Vijuve’s products. On the other hand, Kaspien argues that Vijuve engaged in questionable marketing tactics, which resulted in an extreme spike in Vijuve’s sales velocity and dramatically increased Kaspien’s purchase requirements under the contract. However, when Kaspien tried to ask Vijuve about this spike, Vijuve refused to provide any explanation or assurances and terminated the contract. In this motion, Kaspien argues that Vijuve agreed to limit their ability to recover lost profits. And since Vijuve seeks lost profits stemming from that contract, Kaspien argues, Vijuve is precluded from bringing its sole breach of contract claim. Vijuve disagrees, arguing that genuine issues of material issues of fact exist because an addendum to the contract nullifies the lost profits provision. Based upon the briefing, the caselaw, and the parties’ arguments, the Court grants summary judgment in favor of Kaspien and dismisses Vijuve’s motion to strike as moot. Facts The following facts are drawn from the complaint and the parties’ respective Statements of Material Facts. The facts are construed in the light most favorable to the non-moving party, Vijuve. Vijuve is a company that sells skincare products. Kaspien is an e-commerce company, helping companies provide products to customers through online marketplaces, direct websites, and brick and mortar stores. Kaspien was formerly known as “etailz.” Vijuve and Kaspien signed a contractual agreement on June 6, 2018. The parties agreed that Kaspien would have the exclusive right to market and sell Vijuve’s Anti-Aging Face Massager and Serum products on Amazon. On September 1, 2020, Adeel Imrani, the co-founder of Vijuve, emailed Kunal Chopra, the CEO of Kaspien. In his email, Mr. Imrani noted that, although the partnership had been going well overall, the parties’ sales were down compared to the end of 2019. Mr. Imrani noted several factors that Vijuve believed had contributed to the decline in sales and suggested a plan to increase profits. Specifically, Mr. Imrani proposed that Vijuve would (1) commit to Kaspien being the sole seller of the Massager and Serum on Amazon; (2) implement marketing tactics by pushing traffic from a curated audience via social media channels and our email lists; and (3) increase sales by investing in additional launching strategies. In return, Mr. Imrani requested that Kaspien commit to a new formula for placing its purchase orders for Vijuve’s Massagers and Serum that was based on the past two weeks’ sales velocity. The parties engaged in negotiations regarding Mr. Imrani’s proposal from September 1 to September 18, 2020. On September 18, 2020, Vijuve and Kaspien executed their Retail Partnership and Addendum agreement (the “Contract”), formalizing their agreement. The parties agreed to the following terms. First, Kaspien was subject to a Minimum Order Commitment (“MOC”) to Vijuve. Specifically, under the MOC, if Kaspien’s stock of Vijuve products was less than the last two weeks’ sales velocity (which the Contract defined as confirmed orders plus pending orders), then Kaspien was required to place an order based on the previous two weeks’ sales velocity. Second, the Contract included a “Consequential Damages” clause in Paragraph 20. The term “Partner” in this paragraph refers to Vijuve. The Consequential Damages clause reads as follows: Consequential Damages. In no event shall Kaspien or its affiliate or subsidiaries be liable to Partner or any third party under any theory of tort, contract, strict liability, or other legal or equitable theory of (i) lost profits, lost revenue, loss of business or loss of data, (ii) exemplary, punitive, special, incidental, indirect or consequential damages or the like, or (iii) for cost of cover, recovery or recoupment of any investment, each of which is hereby excluded by agreement of the parties regardless of whether such damages were foreseeable or whether Kaspien has been advised of the possibility of such damages. Throughout the negotiations in September 2020, every exchanged draft included this “Consequential Damages” clause. Third, the Contract included an Addendum which Vijuve argues is an integration provision of the Contract that supersedes any conflicting terms or conditions of the Contract. The pertinent portion of the Addendum provides: To the extent that any terms or conditions contained in this Addendum may contradict or conflict with any of the terms or conditions of the attached Agreement, it is expressly understood and agreed that the terms of this Addendum shall take precedence and supersede the attached Agreement.

Free access — add to your briefcase to read the full text and ask questions with AI

Vijuve Inc v. Kaspien Inc, (E.D. Wash. 2023).

Vijuve Inc v. Kaspien Inc (Vijuve Inc v. Kaspien Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related